Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1994-03-14
2000-02-22
Priebe, Scott D.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
514 44, 536 231, 435 6, 435 691, 4353201, 435325, 435455, A61K 4800, A01N 6300, C12N 1500
Patent
active
06027722&
ABSTRACT:
Improved recombinant retrotransposon vectors for gene transfer are disclosed. The synthetic vectors are truncated so as to reduce or altogether eliminate homologous recombination with retroviral helper sequences found in helper cells used to propagate the vectors, making them safer for use in humans and providing more space for therpeutic genes. The vectors transmit foreign DNA efficiently, are stable, enable abundant RNA expression from the retrotransposon transcriptional promoter, and through their diversity permit many useful applications in therapeutics and transgenics. Methods are described for rescuing tissue-specific spromoters obtaining expression in primary cells, mapping the genome and other techniques of therapeutic and transgenic utility.
REFERENCES:
patent: 4405712 (1983-09-01), Woude et al.
patent: 4615974 (1986-10-01), Kingsman et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4670388 (1987-06-01), Rubin et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4719177 (1988-01-01), Baltimore et al.
patent: 4828987 (1989-05-01), Kopchick et al.
patent: 4861719 (1989-08-01), Miller
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4898823 (1990-02-01), Kingsman et al.
patent: 4918166 (1990-04-01), Kingsman et al.
patent: 4957865 (1990-09-01), Samarut et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5075229 (1991-12-01), Hanson et al.
patent: 5124263 (1992-06-01), Temin et al.
patent: 5162215 (1992-11-01), Bosselman et al.
patent: 5354674 (1994-10-01), Hodgson
patent: 5399346 (1995-03-01), Anderson et al.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al., (ed.), Birhauser, Boston, MA, pp. 433 and 492-495).
French et a., Analytical Biochemistry, vol. 228, 2:354-355, 1995.
Crystal, Science, vol. 270, pp. 404-409, 1995.
Chakraborty et al., Cancer Gene Therapy, vol. 1, 2: 113-118, 1994.
Coghlan, New Scientist, vol. 148, pp. 14-15, 1995.
Mastrangelo et al., vol. 23, 1, pp. 4-21, 1996.
Miller et al., The FASEB J, vol. 9, 190-199, 1995.
Marshall, E., "Gene Therapy's Growing Pains", Science, vol. 269, 1050-1055, (Aug. 25, 1995).
Mullins, J.J., et al., "Transgenesis in Nonmurine Species", Hypertension, 22, No. 4, 630-633, (1993).
Wall, R.J., "Transgenic Livestock: Progress and Prospects for the Future", Theriogenology, 45, 57-68, (1996).
Rogers, J.A., et al., "A Tumor Necrosis Factor-Responsive Long-Term-Culture-Initiating Cell is Associated with the Stromal Layer of Mouse Long-Term Bone Marrow Cultures", Proc. Natl. Acad. Sci. USA, 90, 5777-5780, (Jun., 1993).
"Patent Search: Genetic Vectors, Transduction, Genetic Transfection", Oct. 1990 (a copy of a computer generated search was submitted with the PTO 1449 of the parent application.
Adams, S.E., et al., "Complete Nucleotide Sequence of a Mouse VL30 Retro-Element", Molecular and Cellular Biology, 8, 2989-2998, (Aug., 1988).
Anderson, W.F., "Human Gene Therapy", Science, 256, 808-813, (May, 1992).
Anderson, W.F., "Prospects for Human Gene Therapy", Science, 226, 401-409, (Oct., 1984).
Bestwick, R.K., et al., "Overcoming Interference to Retroviral Superinfection Results in Amplified Expression and Transmission of Cloned Genes", Proc. Natl. Acad. Sci. USA, 85, 5404-5408, (Aug., 1988).
Boeke, J.D., et al., "A General Method for the Chromosomal Amplification of Genes in Yeast", Science, 239, 280-282, (Jan., 1988).
Carter, A.T., et al., "A Novel Approach to Cloning Transcriptionally Active Retrovirus-Like Genetic Elements from Mouse Cells", Nucleic Acids Research,11, 6243-6254, (1983).
Chakraborty, A.K., et al., "Synthetic Retrotransposon VL30 Vectors For Gene Therapy, Transgenics and Research", Miami Short Reports, 99-100, (1994).
Chakraborty, A.K., et al., "Transmission of Endogenous VL30 Retrotransposons by Helper Cells Used in Gene Therapy", Cancer Gene Therapy, 1, 113-118, (1994).
Chakroborty, A.K., et al., "Synthetic Retrotransposon Vectors for Gene Therapy", FASEB Journal, Methodology Communications, 7, 971-977, (Jul., 1993).
Chakroborty, A.K., et al., "Synthetic Retrotransposon VL30 Derived Vectors for Gene Therapy", J. Cell. Biol., Suppl. 17E, Abstract No. SZ 302, 235, (1993).
Cook, R.F., et al., "Liver-Specific Expression of a Phosphoenolpyruvate Carboxykinase-neo Gene in Genetically Modified Chickens", Poultry Science, 72, 554-567, (1993).
Cook, R.F., et al., "Retrotransposon Gene Engineering", Bio/Technology, 9, 748-751, (Aug., 1991).
Cosgrove, D.E., et al., "Transgenic Animal Models and Gene Therapy", Exp. Opin. Ther. Patents, 4, 237-245, (1994).
Cosgrove, et al., "VL30 Vectoring Systems: Some Surprises in Their Regulation in Embryonic Stem Cells", J. Cell. Biochem., Suppl. 17E, Abstract No. SZ 303, 235, (1993).
Culver, K.W., et al., "Gene Therapy for Cancer", TIG, 10, 174-178, (May, 1994).
Donahue, R.E., et al., "Helper Virus Induced T Cell Lymphoma in Nonhuman Primates After Retroviral Mediated Gene Transfer", J. Exp. Med., 176, 1125-1135, (Oct., 1992).
First, N.L., "New Animal Breeding Techniques and Their Application", J. Reprod. Fertil., Suppl. 41, 3-14, (1990).
Foster, D.N., et al., "Isolation of Mouse DNA Segments Containing Epidermal Growth Factor (EGF) Inducible Sequences", J. Cell Biochem., (Suppl), 6, 285, (1982).
Foster, D.N., et al., "Polyadenylylated RNA Complementary to a Mouse Retrovirus-Like Multigene Family is Rapidly and Specifically Induced by Epidermal Growth Factor Stimulation of Quiescent Cells", Proc. Nat'l Acad. Sci. USA, 79, 7317-7321, (Dec., 1982).
Giri, C.P., et al., "Discrete Regions of Sequence Homology Between Cloned Rodent VL30 Genetic Elements and AKV-Related MuLV Provirus Genomes", Nucleic Acids Research, 11, 305-319, (1983).
Hatzoglou, M., et al., "Dexamethasone Regulated Expression of Mouse VL30 Retrotransposons in Rat Cells Upon Infection with Recombinant MoMLV Viruses", J. Cell. Biochem., Abstract D411, 368, (1990).
Hatzoglou, M., et al., "Efficient Packaging of a Specific VL30 Retroelement by .psi.2 Cells Which Produce MoMLV Recombinant Retroviruses", Human Gene Therapy, 1, 385-397, (1990).
Hatzoglou, M., et al., "Hepatic Gene Transfer in Animals Using Retroviruses Containing the Promoter from the Gene for Phosphoenolpyruvate Carboxykinase", Journal of Biological Chemistry, 265, 17285-17293, (Oct., 1990).
Hennighausen, L., "The Mammary Gland as a Bioreactor: Production of Foreign Proteins in Milk", In: Protein Expression and Purification, vol. 1, 3-8, (1990).
Hodgson, C.P., et al., "Gene Engineering with Retrotransposon Vectors", Advances in Gene Technology: The Molecular Biology of Human Genetic Disease, Miami Symposia, 44, (1991).
Hodgson, C.P., et al., "Mouse Retrovirus-Like (VL30) Transposable Element RNA is Abundantly Expressed in PSI-2 Helper Cells, Transferred to Recipient Rat Hepatoma Cells, and Expressed in a Dexamethasone-Inducible Fashion Along with Specifically Vectored Sequences: Complete Structure", J. Cellu. Biochem., 13D, 54, (1989).
Hodgson, C.P., et al., "Nucleotide Sequence of Mouse Virus-like (VL30) Retrotransposon BVL-1", Nucleic Acids Research, 18, 673, (1990).
Hodgson, C.P., et al., "Retroviral Vectors for Gene Therapy and Transgenics", Curr. Opin. Invest. Drugs, 2, 205-216, (Mar., 1993).
Hodgson, C.P., et al., "Retroviral Vectors for Gene Therapy and Transgenics", Curr. Opin. Therap. Patents, 3, 223-235, (Feb., 1993).
Hodgson, C.P., et al., "Structure and Expression of Mouse VL30 Genes", Molec. Cell. Biol., 3, 2221-2231, (Dec., 1983).
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene", Dissertation Abstracts International, 44, 700B, (1983).
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of a Mouse Virus-Like Genetic Element", DNA, 2, 83, (1983).
Hodgson, C.P., et al., "The Long Terminal Repeats and Associated Flanking Sequences of an Integrated Mouse VL30 Gene", Doctoral Dissertation, University of Minnesota, (Feb., 1983).
Hoeben, R.C., et al., "Inactivation of the Moloney Murine Leukemia Virus Long Terminal Repeat in Murine Fibroblast Cel
Nature Technology Corporation
Nguyen Dave Trong
Priebe Scott D.
LandOfFree
Vectors for gene transfer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors for gene transfer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors for gene transfer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-518108